Trials / Completed
CompletedNCT00627536
Scar-Improvement Efficacy and Safety of a Single Intradermal Injection of Avotermin (Juvista) Administered Following Full-Thickness Skin Incisions
A Double-Blind, Placebo-Controlled, Randomised Dose-Ranging Trial to Investigate the Efficacy of Avotermin (Juvista) in the Improvement of Scar Appearance When Applied to Approximated Wound Margins in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Renovo · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
This study was undertaken to investigate the scar-improvement efficacy and safety of a single dose of avotermin (Juvista) injection into skin incisions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Avotermin | A single intradermal injection of avotermin administered at the dose to both margins of a full-thickness incision immediately following closure. |
| DRUG | Placebo | Matched to avotermin dosage strength |
Timeline
- Start date
- 2006-07-01
- Primary completion
- 2007-03-01
- Completion
- 2007-03-01
- First posted
- 2008-03-03
- Last updated
- 2008-03-04
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00627536. Inclusion in this directory is not an endorsement.